Your Article Summary
Sandoz launches first generic version of Prograf capsules
Novartis, 08/12/09
Sandoz announced the introduction of tacrolimus capsules, a generic equivalent of Prograf, in the US. Tacrolimus is an immunosuppressive treatment used to help prevent rejection of a kidney or liver transplant. Sandoz is the first and only company to launch generic tacrolimus in the US, delivering on its strategy of being first–to–market with key products. With the introduction of tacrolimus, Sandoz is expanding patient access to cost–saving transplant treatment options in the US.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN
Allos Therapeutics, 12/01/09
Article Search
Sponsor


See Latest Articles


